Early Echocardiographic and Serum Biomarkers Predict Thrombotic Microangiopathy, Endotheliopathy, and Survival After Pediatric Hematopoietic Stem Cell Transplant.
Saved in:
| Title: | Early Echocardiographic and Serum Biomarkers Predict Thrombotic Microangiopathy, Endotheliopathy, and Survival After Pediatric Hematopoietic Stem Cell Transplant. |
|---|---|
| Authors: | Smith MA; Division of Pediatric Critical Care, Department of Pediatrics, University of California, San Francisco, California; Pediatric Pulmonary Hypertension Program, Department of Pediatrics, University of California, San Francisco, California. Electronic address: Michael.smith2@ucsf.edu., Hutchinson Z; Division of Pediatric Cardiology, Department of Pediatrics, University of California, San Francisco, California., Colglazier E; Pediatric Pulmonary Hypertension Program, Department of Pediatrics, University of California, San Francisco, California., Parker C; Pediatric Pulmonary Hypertension Program, Department of Pediatrics, University of California, San Francisco, California., Higham CS; Division of Allergy, Immunology, and Bone Marrow Transplantation, Department of Pediatrics, University of California, San Francisco, California., Fineman JR; Division of Pediatric Critical Care, Department of Pediatrics, University of California, San Francisco, California; Pediatric Pulmonary Hypertension Program, Department of Pediatrics, University of California, San Francisco, California., Zinter MS; Division of Pediatric Critical Care, Department of Pediatrics, University of California, San Francisco, California., Dvorak CC; Division of Allergy, Immunology, and Bone Marrow Transplantation, Department of Pediatrics, University of California, San Francisco, California., Nawaytou HM; Pediatric Pulmonary Hypertension Program, Department of Pediatrics, University of California, San Francisco, California; Division of Pediatric Cardiology, Department of Pediatrics, University of California, San Francisco, California. |
| Source: | Transplantation and cellular therapy [Transplant Cell Ther] 2026 Mar; Vol. 32 (3), pp. 306.e1-306.e13. Date of Electronic Publication: 2025 Nov 15. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
